The test uses mass spectrometry to measure several proteins to assess the likelihood that an individual has the brain amyloid pathology associated with Alzheimer's disease.

C2N currently offers the Precivity™ line of blood tests for patients 50 and older with signs or symptoms of mild cognitive impairment or dementia. The tests help inform medical management and ...

Star hopes its drug, which is currently in late-stage testing, might prove a more convenient, longer-lasting alternative to ...

Guardant’s screen could see annual sales of $50 billion. The company hopes to use the technology to detect hundreds of other diseases.

The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, making the test the first to get signoff to aid in the early detection of the ...

As the world’s population ages, health experts are bracing for higher rates of age-related diseases, including Alzheimer’s. Finding new ways to diagnose the condition is more of a priority than ever, ...

Edward Chernoff, attorney for Dr. Conrad Murray, who tried to revive Jackson at the singer's rented home, said the doctor was not aware of any prescription drug abuse by Jackson. "I think those are ...

The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older. The maker of the test, Palo Alto, California-based ...

Cirrhosis and liver cancer are two of the world’s leading causes of illness and death, but they typically creep up quietly.

Abstract: Medical technologists are integral to public health, providing critical expertise in drug testing and blood banking. This article explores their role in ensuring accurate testing, ...